LPAR2

LPAR2 (lysophosphatidic acid receptor 2) is a G protein-coupled receptor for lysophosphatidic acid (LPA) that couples predominantly to G_i/o, G_q, and G_12/13 signaling pathways, thereby regulating cell survival, apoptosis resistance, migration, cytokine production, and other context-dependent cellular responses^[1][5]. LPAR2 functions within the broader LPA-LPAR signaling network, but it is particularly associated with pro-survival signaling and inhibition of apoptosis, distinguishing it from receptor subtypes such as LPAR1, which are more strongly linked to cell motility and invasion^[5][2]. Mechanistically, LPAR2 contains a distinctive C-terminal protein-interaction region that enables binding to scaffold proteins including NHERF2 and MAGI-3, creating receptor-specific signaling complexes that modulate downstream pathways such as ERK, Akt, RhoA, phospholipase C, NF-κB, and JNK signaling^[3]. In disease models, elevated LPAR2 expression has been reported in several malignancies, including colorectal, ovarian, breast, thyroid, and endometrial cancers, where LPAR2 signaling contributes to proliferation, survival, migration, invasion, inflammatory mediator production, and tumor progression^[2][4]. Experimental studies further demonstrate that genetic deletion or suppression of LPAR2 attenuates tumor-promoting and inflammatory responses in colorectal cancer models, supporting its utility as a mechanistic target for cancer biology research^[4][6]. Compared with related isoforms, the unique PDZ-domain-mediated signaling architecture of LPAR2 provides an important experimental framework for dissecting receptor-specific functions within the LPA signaling system^[3]. For experimental applications, selective modulation of LPAR2 activity has been used to investigate cancer-associated signaling, apoptosis regulation, cell migration, and inflammation-related pathways^[2][4].